Huadong Medicine Revenue vs. Return On Asset
| 000963 Stock | 36.10 0.09 0.25% |
Total Revenue | First Reported 2002-06-30 | Previous Quarter 10.4 B | Current Value 10.6 B | Quarterly Volatility 3.4 B |
For Huadong Medicine profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Huadong Medicine to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Huadong Medicine Co utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Huadong Medicine's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Huadong Medicine Co over time as well as its relative position and ranking within its peers.
Huadong |
Huadong Medicine Return On Asset vs. Revenue Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Huadong Medicine's current stock value. Our valuation model uses many indicators to compare Huadong Medicine value to that of its competitors to determine the firm's financial worth. Huadong Medicine Co is the top company in revenue category among its peers. It also is number one stock in return on asset category among its peers . The ratio of Revenue to Return On Asset for Huadong Medicine Co is about 605,421,498,063 . At present, Huadong Medicine's Total Revenue is projected to increase significantly based on the last few years of reporting. Comparative valuation analysis is a catch-all model that can be used if you cannot value Huadong Medicine by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Huadong Medicine's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Huadong Revenue vs. Competition
Huadong Medicine Co is the top company in revenue category among its peers. Market size based on revenue of Health Care industry is presently estimated at about 8.7 Trillion. Huadong Medicine adds roughly 40.62 Billion in revenue claiming only tiny portion of equities under Health Care industry.
Huadong Return On Asset vs. Revenue
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Huadong Medicine |
| = | 40.62 B |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Huadong Medicine |
| = | 0.0671 |
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
Huadong Return On Asset Comparison
Huadong Medicine is currently under evaluation in return on asset category among its peers.
Huadong Medicine Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Huadong Medicine, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Huadong Medicine will eventually generate negative long term returns. The profitability progress is the general direction of Huadong Medicine's change in net profit over the period of time. It can combine multiple indicators of Huadong Medicine, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Operating Income | 3.8 B | 4 B | |
| Income Before Tax | 3.5 B | 3.6 B | |
| Net Income Applicable To Common Shares | 2.6 B | 2.8 B | |
| Net Income | 2.8 B | 3 B | |
| Income Tax Expense | 562.2 M | 590.4 M | |
| Net Income From Continuing Ops | 2.8 B | 2.5 B | |
| Total Other Income Expense Net | -6.4 M | -6.7 M | |
| Net Interest Income | -46.8 M | -49.2 M | |
| Interest Income | 94 M | 64 M | |
| Change To Netincome | 261.1 M | 142.3 M |
Huadong Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Huadong Medicine. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Huadong Medicine position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Huadong Medicine's important profitability drivers and their relationship over time.
Use Huadong Medicine in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Huadong Medicine position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Huadong Medicine will appreciate offsetting losses from the drop in the long position's value.Huadong Medicine Pair Trading
Huadong Medicine Co Pair Trading Analysis
The ability to find closely correlated positions to Huadong Medicine could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Huadong Medicine when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Huadong Medicine - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Huadong Medicine Co to buy it.
The correlation of Huadong Medicine is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Huadong Medicine moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Huadong Medicine moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Huadong Medicine can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Huadong Medicine position
In addition to having Huadong Medicine in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Munis Funds Thematic Idea Now
Munis Funds
Funds or Etfs that invest in fixed income securities issued by states, cities, and towns as well as other public entities. The Munis Funds theme has 38 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Munis Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Huadong Stock
To fully project Huadong Medicine's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Huadong Medicine at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Huadong Medicine's income statement, its balance sheet, and the statement of cash flows.